IceCure Medical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for IceCure Medical stock have an average target of 2.95, with a low estimate of 2.90 and a high estimate of 3.00. The average target predicts an increase of 298.00% from the current stock price of 0.74.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.90	$2.95	$3.00	$3.00
Change	+291.26%	+298.00%	+304.75%	+304.75%

Analyst Ratings

The average analyst rating for ICCM stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '24	Feb '24	Mar '24	Apr '24	May '24	Jun '24
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+304.75%	Jun 5, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+304.75%	May 29, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+304.75%	Apr 16, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+304.75%	Apr 4, 2024
Ben Haynor Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $1.9 → $2.9	Strong Buy	Maintains	$1.9 → $2.9	+291.26%	Mar 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

3.77M

from 3.23M

16.85%

from 3.23M

Revenue Next Year

5.93M

from 3.77M

57.25%

from 3.77M

EPS This Year

-0.30

from -0.32

EPS Next Year

-0.27

from -0.30

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	1.63M	3.87M	4.14M	3.09M	3.23M	3.77M	5.93M	34.55M	62.45M	89.75M
Revenue Growth	-	137.74%	6.98%	-25.45%	4.67%	16.85%	57.25%	482.27%	80.76%	43.72%
EPS	-0.33	-0.22	-0.35	-0.46	-0.32	-0.30	-0.27	-	0.27	0.38
EPS Growth	-	-	-	-	-	-	-	-	-	42.31%
Forward PE	-	-	-	-	-	-	-	-	2.79	1.96
No. Analysts	-	-	-	-	-	6	6	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	4.0M	6.1M	35.6M	64.3M	92.4M
Avg	3.8M	5.9M	34.5M	62.4M	89.7M
Low	3.5M	5.7M	33.2M	60.0M	86.2M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	25.4%	62.8%	499.4%	86.1%	48.0%
Avg	16.8%	57.2%	482.3%	80.8%	43.7%
Low	7.5%	50.2%	459.4%	73.7%	38.1%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-0.30	-0.27	-	0.27	0.39
Avg	-0.30	-0.27	-	0.27	0.38
Low	-0.29	-0.26	-	0.25	0.36

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	-	46.5%
Avg	-	-	-	-	42.3%
Low	-	-	-	-	36.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.